Back
Ascendis Pharma AS Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
ASND
Ascendis Pharma AS
Last Price:
$158.86
Seasonality Move:
2.33%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing buying pressure, which is a positive indicator for future bullish movement.
Ascendis Pharma AS Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 157.41 | Buy |
20-day SMA: | 161.86 | Sell |
50-day SMA: | 157.37 | Buy |
200-day SMA: | 139.82 | Buy |
8-day EMA: | 159.03 | Buy |
20-day EMA: | 159.52 | Buy |
50-day EMA: | 156.02 | Buy |
200-day EMA: | 143.04 | Buy |
Ascendis Pharma AS Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.43 | Buy |
Relative Strength Index (14 RSI): | 51.58 | Buy |
Chaikin Money Flow: | 431761 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (155.94 - 166.54) | Sell |
Bollinger Bands (100): | (133.15 - 161.33) | Buy |
Ascendis Pharma AS Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ascendis Pharma AS Stock
Is Ascendis Pharma AS Stock a Buy?
-
Ascendis Pharma AS share price is 160.33 while ASND 8-day simple moving average is 157.41, which is a Buy signal.
-
The stock price of ASND is 160.33 while Ascendis Pharma AS 20-day SMA is 161.86, which makes it a Sell.
-
Ascendis Pharma AS 50-day simple moving average is 157.37 while ASND share price is 160.33, making it a Buy technically.
-
ASND stock price is 160.33 and Ascendis Pharma AS 200-day simple moving average is 139.82, creating a Buy signal.
ASND Technical Analysis vs Fundamental Analysis
Sell
33
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy or a Sell?
-
Ascendis Pharma AS stock is rated a SellThe current Ascendis Pharma AS [ASND] share price is $160.33. The Score for ASND is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Ascendis Pharma AS Stock Info
Market Cap:
9.7B
Price in USD:
160.33
Share Volume:
443.1K
Ascendis Pharma AS 52-Week Range
52-Week High:
183.00
52-Week Low:
111.09
Sell
33
Ascendis Pharma AS (ASND)
is a Sell
Ascendis Pharma AS Share Price Forecast
-
What is the Ascendis Pharma AS stock price today?The Ascendis Pharma AS stock price is 160.33 USD today.
-
Will ASND stock go up or go down?Ascendis Pharma AS> share price is forecast to RISE/FALL based on technical indicators
-
Is Ascendis Pharma AS overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ascendis Pharma AS is overvalued.
Is Ascendis Pharma AS Stock a Buy?
-
Ascendis Pharma AS share price is 160.33 while ASND 8-day exponential moving average is 159.03, which is a Buy signal.
-
The stock price of ASND is 160.33 while Ascendis Pharma AS 20-day EMA is 159.52, which makes it a Buy.
-
Ascendis Pharma AS 50-day exponential moving average is 156.02 while ASND share price is 160.33, making it a Buy technically.
-
ASND stock price is 160.33 and Ascendis Pharma AS 200-day simple moving average is 143.04, creating a Buy signal.
Fundamental Analysis of Ascendis Pharma AS
Is Ascendis Pharma AS a good investment?
-
Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.59 per share, an increase this year of $2.02 per share, and an increase next year of $7.29 per share.
Technical Analysis of Ascendis Pharma AS
Should I short Ascendis Pharma AS stock?
-
ASND Moving Average Covergence Divergence (MACD) indicator is 0.43, suggesting Ascendis Pharma AS is a Buy
-
Ascendis Pharma AS Relative Strength Index (RSI) is 51.58, which suggest Ascendis Pharma AS is overbought
-
The Bollinger Bands (25) for Ascendis Pharma AS is (155.94 - 166.54), which suggest Ascendis Pharma AS is a Buy
-
The Bollinger Bands (100) for Ascendis Pharma AS is (133.15 - 161.33), which suggest Ascendis Pharma AS is a Buy
* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.